Acorda annouces pricing AMPYRA

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Acorda annouces pricing AMPYRA

Postby Bear2 » Wed Feb 03, 2010 6:04 am

Formally called Fampridine-SR is now called AMPYRA and priced according to the ms drug method of $$$$.



http://phoenix.corporate-ir.net/phoenix ... highlight=



Jim
User avatar
Bear2
Family Member
 
Posts: 47
Joined: Thu Aug 13, 2009 2:00 pm

Advertisement

Postby CureOrBust » Thu Feb 04, 2010 4:08 pm

very interesting. I used to pay around $100 (approx from memory) for around 2 months supply (100 capsules at 1-2 a day) of compounded slow release 4-AP capsules.

Does the release of this medication in anyway stop or hinder compounding pharmacies from providing their product?
User avatar
CureOrBust
Family Elder
 
Posts: 2933
Joined: Wed Jul 27, 2005 2:00 pm
Location: Sydney, Australia

Postby Bear2 » Thu Feb 04, 2010 5:55 pm

I don't think so.
User avatar
Bear2
Family Member
 
Posts: 47
Joined: Thu Aug 13, 2009 2:00 pm

Postby Frank » Fri Feb 05, 2010 4:17 pm

@cure:
Is the pharmacy-compounded product chemically exactly the same as the now approved AMPYRA?

If so, how was ACORDA able to get a patent on it, when its an already known and used compound?
But if they have got a patent then I would suspect this would prohibit the production of 4-AP by any other party (including pharmacists).

Thanks
--Frank
Treatment: Gilenya since 01/2011, CCSVI both IJV ballooned 09/2010, Tysabri stopped after 24 Infusions and positive JCV antibody test, after LDN, ABX Wheldon Regime for 1 year.
Frank
Family Elder
 
Posts: 543
Joined: Wed Jan 03, 2007 3:00 pm
Location: Germany

Postby Algis » Sat Feb 06, 2010 2:19 am

"Acorda's goal is to ensure that cost is not a barrier to any person with MS who may benefit from this important medication, regardless of their level of income or healthcare coverage," said Ron Cohen, M.D., President and CEO of Acorda Therapeutics.

That's a joke?

A 1,000 bucks a month... :roll:

They really take us as the milking cow :P
User avatar
Algis
Family Elder
 
Posts: 783
Joined: Sat Nov 21, 2009 3:00 pm
Location: XinDian, Taiwan

Postby Frank » Sun Feb 07, 2010 6:22 am

I really wonder how they are going to generate adequate sales volume.

I regard my health insurance as to be pretty good (private health insurance in germany) but I rather doubt that they are willing to cover a moderately effective symptomatic drug to improve my gait for 1000 $/month.
Individuals who are able/willing to pay that ammount of money out of their pocket will also be hard to find.

Eventually they will certainly find some people / insurances that would cover the cost but I do think they could reach much higher overall sales in USD if they offered their drug for - lets say - 100 USD/month, because I assume many more people / insurances would accept it then.

--Frank
Treatment: Gilenya since 01/2011, CCSVI both IJV ballooned 09/2010, Tysabri stopped after 24 Infusions and positive JCV antibody test, after LDN, ABX Wheldon Regime for 1 year.
Frank
Family Elder
 
Posts: 543
Joined: Wed Jan 03, 2007 3:00 pm
Location: Germany


Return to Drug Pipeline

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service